{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T04:21:03Z","timestamp":1729225263908,"version":"3.27.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jad.2024.08.183","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T16:19:20Z","timestamp":1724861960000},"page":"281-285","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The effect of intranasal (R,S)-ketamine on symptoms of fatigue in severe major depressive disorder or bipolar depression with and without comorbid alcohol use disorder: Results from a randomized, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"367","author":[{"given":"Rodrigo","family":"Machado-Vieira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory H.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan C.","family":"Courtes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C.","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney M.","family":"Vecera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioline D.","family":"Henter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Carlos A.","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jair C.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2024.08.183_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109610","article-title":"Altered in vivo brain GABA and glutamate levels are associated with multiple sclerosis central fatigue","volume":"137","author":"Arm","year":"2021","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.jad.2024.08.183_bb0010","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.cca.2012.06.022","article-title":"NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome","volume":"413","author":"Armstrong","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jad.2024.08.183_bb0015","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20176432","article-title":"Physical exercise-induced fatigue: the role of serotonergic and dopaminergic systems","volume":"50","author":"Cordeiro","year":"2017","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.jad.2024.08.183_bb0020","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1177\/1352458520936226","article-title":"Pilot randomized active-placebo controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigue","volume":"27","author":"Fitzgerald","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jad.2024.08.183_bb0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jad.2024.07.016","article-title":"Prevalence and factors associated with fatigue in patients with major depressive disorder or bipolar disorder","volume":"362","author":"Gao","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.08.183_bb0030","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1023\/B:NERE.0000021243.86287.43","article-title":"Altered neuronal-glial signaling in glutamatergic transmission as a unifying mechanism in chronic pain and mental fatigue","volume":"29","author":"Hansson","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jad.2024.08.183_bb0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1017\/S0033291798007934","article-title":"Unique genetic and environmental determinants of prolonged fatigue: a twin study","volume":"29","author":"Hickie","year":"1999","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2024.08.183_bb0040","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5152\/alphapsychiatry.2023.231358","article-title":"Ketamine and electroconvulsive therapy for treatment-refractory depression","volume":"24","author":"Huang","year":"2023","journal-title":"Alpha Psychiatry"},{"key":"10.1016\/j.jad.2024.08.183_bb0045","doi-asserted-by":"crossref","unstructured":"Jones, G.H., Vecera, C.M., Ruiz, A.C., Wu, H.E., McInturff, S.I., Orejarena, M.J., et al., 2024. A randomized, double-blind, placebo-controleld pilot trial of the acute anti-suicidal and antidepressant effects of intranasal (R,S)-ketamine in severe unipolar and bipolar depression with and without comorbid alcohol use disorder. J. Clin. Psychiatry 85, 23m14974.","DOI":"10.4088\/JCP.23m14974"},{"key":"10.1016\/j.jad.2024.08.183_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jpsychores.2018.09.002","article-title":"Vital exhaustion and risk of alcohol use disorders: a prospective cohort study","volume":"114","author":"Just-\u00d8stergaard","year":"2018","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.jad.2024.08.183_bb0055","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/sj.npp.1300252","article-title":"Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients","volume":"28","author":"Krystal","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2024.08.183_bb0060","article-title":"Which depressive symptoms and medication side effects are perceived by patients as interfering most with occupational functioning?","volume":"2012","author":"Lam","year":"2012","journal-title":"Depress. Res. Treat."},{"key":"10.1016\/j.jad.2024.08.183_bb0065","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/bdi.12003","article-title":"Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression","volume":"14","author":"Luckenbaugh","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2024.08.183_bb0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/bja\/77.2.203","article-title":"Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children","volume":"77","author":"Malinovsky","year":"1996","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jad.2024.08.183_bb0075","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.183_bb0080","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2010.06.003","article-title":"Glial and glutamatergic markers in depression, alcoholism, and their comorbidity","volume":"127","author":"Miguel-Hidalgo","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.08.183_bb0085","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jpsychires.2009.09.006","article-title":"Bipolar disorder comorbid with alcoholism: a 1H magnetic resonance spectroscopy study","volume":"44","author":"Nery","year":"2010","journal-title":"J. Psychiatr. Res."},{"issue":"Suppl. 3","key":"10.1016\/j.jad.2024.08.183_bb0090","first-page":"30S","article-title":"A review of psychostimulants for adults with depression","volume":"32","author":"Pary","year":"2015","journal-title":"Fed. Pract."},{"key":"10.1016\/j.jad.2024.08.183_bb0095","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/ijerph15040771","article-title":"Predictors of response to ketamine in treatment resistant major depressive disorder and bipolar disorder","volume":"15","author":"Rong","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jad.2024.08.183_bb0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-2094-1-22","article-title":"On the potential role of glutamate transport in mental fatigue","volume":"1","author":"R\u00f6nnb\u00e4ck","year":"2004","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jad.2024.08.183_bb0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jpsychires.2015.06.012","article-title":"Development of a clinician-administered National Institutes of Health-brief fatigue inventory: a measure of fatigue in the context of depressive disorders","volume":"68","author":"Saligan","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2024.08.183_bb0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jad.2016.01.009","article-title":"An assessment of the anti-fatigue effects of ketamine from a double-blind, placebo-controlled, crossover study in bipolar disorder","volume":"194","author":"Saligan","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.08.183_bb0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jad.2018.10.089","article-title":"Disentangling the association of depression on the anti-fatigue effects of ketamine","volume":"244","author":"Saligan","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2024.08.183_bb0120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1479-5876-11-93","article-title":"Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology","volume":"11","author":"Stringer","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jad.2024.08.183_bb0125","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1017\/S0033291799008697","article-title":"Fatigue and psychiatric disorder: different or the same?","volume":"29","author":"Van Der Linden","year":"1999","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2024.08.183_bb0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2334-6-15","article-title":"Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus","volume":"6","author":"Vernon","year":"2006","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jad.2024.08.183_bb0135","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2024.08.183_bb0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bdd.336","article-title":"Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers","volume":"24","author":"Yanagihara","year":"2003","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.jad.2024.08.183_bb0145","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1080\/14656566.2021.1951225","article-title":"Key considerations in the pharmacological management of treatment-resistant depression","volume":"22","author":"Yavi","year":"2021","journal-title":"Expert Opin. Pharmacother."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724014149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032724014149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T07:28:54Z","timestamp":1729150134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032724014149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":29,"alternative-id":["S0165032724014149"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2024.08.183","relation":{},"ISSN":["0165-0327"],"issn-type":[{"type":"print","value":"0165-0327"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of intranasal (R,S)-ketamine on symptoms of fatigue in severe major depressive disorder or bipolar depression with and without comorbid alcohol use disorder: Results from a randomized, double-blind, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2024.08.183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}